STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom ...
Market Growing for Custom-Made Peptides July 1, 2006 July 1, 2006 (Vol. 26, No. 13) Expansion Attributed to Increased Use in Drug and Vaccine Development Continued growth and a changing landscape ...
Peptide synthesis is no longer just a laboratory utility, growing at a CAGR of over 8%. Within this sector, biotinylation—the process of covalently attaching biotin to a peptide—represents one of the ...
Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom peptide revolution. Automated Custom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results